DCB Bank Q1: PAT up 36% YoY to ₹213 Cr as provisions halve; operating profit flat
PAT +35.57% YoY · revenue +9.42% · margins expanding
₹1,984.31 Cr
+9.42% YoY
₹213.2 Cr
+35.57% YoY
9.78%
+2.1pp YoY
₹6.62
DCB Bank reported standalone net profit of ₹213.20 Cr for Q1 FY27 (quarter ended June 30, 2026), up 35.6% year-on-year from ₹157.26 Cr and 3.7% sequentially from ₹205.65 Cr. The headline growth is overwhelmingly provision-led rather than operating-led: operating profit before provisions rose just 5.2% YoY to ₹344.04 Cr, while provisions and contingencies fell ~50% to ₹57.07 Cr (from ₹115.14 Cr a year ago), and this ₹58 Cr swing is essentially the entire profit uplift. Interest earned grew 9.4% YoY to ₹1,984.31 Cr and total income 6.4% to ₹2,180.64 Cr, but other income actually fell to ₹196.33 Cr (from ₹236.12 Cr), reflecting a weaker treasury quarter. Net profit margin on total income expanded to 9.78% (from 7.67% YoY), and annualised RoA improved to 0.96% from 0.81%.
Q1 FY-2027 vs prior quarters
The profit mix shifted sharply by segment: Retail Banking PBT jumped to ₹191.14 Cr from ₹57.40 Cr a year ago and Corporate/Wholesale to ₹43.34 Cr from ₹5.51 Cr, while Treasury Operations collapsed to ₹12.20 Cr from ₹120.47 Cr — consistent with the drop in other income. Asset quality drove the lower provisioning: Gross NPA improved to 2.43% (from 2.98% YoY) and Net NPA to 0.84% (from 1.22%), with the bank carrying additional floating provisions of ₹210.23 Cr on advances. Capital adequacy rose to 17.03% (from 16.55% in Q4), giving headroom ahead of the capital raise management flagged for late Q2/early Q3 FY27.
The stock went into the print at ₹187.33, up 1% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 4 consecutive quarters; revenue is at a 6-quarter high.
Management guides for continued asset growth around 18-20%, with mortgage growth accelerating while co-lending growth moderates to match the bank's overall pace. Net interest margins are expected to see continued benefits from deposit repricing into Q2 FY27, supported by a long-term focus on improving the CASA mix. The
— This quarter: met
Against the prior concall guidance (bullish tone, ~18-20% asset growth, credit costs below 45 bps, margin benefit from deposit repricing into Q2), the quarter reads as broadly on-track on credit costs — the sharp provision drop confirms benign asset quality — but total segment assets grew ~14.7% YoY to ₹88,752 Cr, a touch below the 18-20% asset-growth guide. No formal Street consensus for this specific quarter was locatable in previews. The result is genuinely strong on the bottom line and asset quality, but the flat operating profit and softer treasury/other income mean the earnings quality is thinner than the +36% print suggests; sustained delivery now depends on core operating leverage rather than a further fall in credit costs.
W1
Whether operating profit growth reaccelerates from just +5.2% YoY — profit is currently propped by the ₹58 Cr provision drop, not core operating leverage
W2
The flagged capital raise in late Q2/early Q3 FY27, with CAR already at 17.03%
W3
Asset growth vs the 18-20% guide — total segment assets grew ~14.7% YoY, below the guided pace; and NIM benefit from deposit repricing into Q2 per prior concall
Bank format. revenueFromOperations = Interest Earned ₹1,984.31 Cr (matches DB revenue convention). totalExpenses ₹1,836.60 Cr is 'Total Expenditure excl. provisions'; PBT reconciles after Provisions & Contingencies of ₹57.07 Cr (Total Income 2,180.64 − Expenditure 1,836.60 − Provisions 57.07 = PBT 286.97). No exceptional/extraordinary items either period. No consolidated statement — Note 15: bank has no subsidiaries/associates. Clean digital PDF, limited-reviewed.
Strong PAT growth masks the revenue stumble—and the market has already noticed
Profit surged 35.6% on cost compression, but revenue crawled at 9.4% while assets grew 17–20%. The post-result pop faded by day 5, and the earnings call raised more questions than it answered about whether this bank can grow the top line again.
Where the profit came from
Reported PAT jumped ₹213.2 Cr, up 35.6% year-on-year—the highest quarterly profit in the bank's history. But headline earnings never tell the full story. The engine here is not revenue expansion; it's cost discipline and a shrinking deposit rate environment that may be tightening as you read this.
₹213.2 Cr
+35.6% YoY, +3.7% QoQ
₹1,984 Cr
+9.4% YoY, +4.0% QoQ
3.35%
+15 bps YoY
2.42%
historical low, beat 2.5% guide by 8 bps
The profit-to-revenue gap is the quarter. Advances grew 17.06% year-on-year, deposits 20.06%, yet revenue limped to 9.4%. That 55% gap between asset growth and revenue growth is not a reporting anomaly—it's a yield problem. The bank's deposit repricing benefit (cost-of-deposit down 14 basis points quarter-on-quarter) and falling cost-to-average-assets (2.42% vs. prior guidance of ~2.5%) did the heavy lifting. Fee income spiked 31% year-on-year to ₹175 Cr, but this sits atop a ₹85 Cr treasury loss, and management flagged Q1 as seasonally weak; sustainability is unclear. Strip out the cost wins and this is a mid-single-digit organic quarter.
Highest ever quarterly profit
PAT ₹213.2 Cr, 35.6% YoY growth
Supported
Asset growth 18–20%; mortgages accelerating
Advances 17.06% YoY (met floor); mortgages 10% YoY, 1% QoQ
Overstated
NIM benefits from deposit repricing into Q2
NIM 3.35% (+15 bps YoY); cost-of-deposit −14 bps QoQ; now guides 7–8% decline forward
Mixed—benefit fading faster
Cost-to-average-assets maintained ~2.5%
2.42% delivered; beat by 8 bps
Supported
Revenue growth driven by deposit and advance momentum
Revenue 9.4% YoY vs. 17–20% asset growth
Contradicted
What changed on this call
Management held firm on FY27 ROE guidance (13.5%) and cost targets (2.5%), and all quarterly near-term metrics were met. But the underlying narrative shifted in three ways:
Mortgage growth outlook dimmed: was 'accelerating,' delivered 10% YoY, 1% QoQ. Blamed internal strategy shift (stopped DA sourcing for quality reasons); expects 22–23% growth if 35% disbursal momentum holds, but proof deferred to Q2–Q3.
Deposit repricing benefit halving: achieved 14 bps reduction Q4-to-Q1, now guides 7–8% decline forward. Repricing tail into Q2 still present but shortening; management walked back prior optimism without full transparency on why.
Capital raise deferred: prior call suggested late Q2 or early Q3 FY27. Now says 'no urgency'; Tier 1 capital improved to 14.9% and CRAR to 17.03%. Timing and quantum TBD by board—signals slower capex ambitions or more cautious deployment.
MSME/SME acknowledged as drag: disbursals down year-on-year for several quarters. Stopped TReDS (low-yielding), hiring specialists, targeting Q2–Q3 inflection. Repositioned as 'investment phase,' not structural weakness—credibility still unproven.
The bull case vs. the bear case
Cost discipline is real: 11.06 Cr business per employee (all-time high), achieved on only 11,554 headcount vs. 11,896 two years ago despite 18.5% growth. Opex-to-asset ratio at historical low (2.42%) with headroom to 2.45% guided.
Asset quality improving: GNPA down 55 bps year-on-year to 2.43% (7-year low), NNPA down 38 bps to 0.84%. Credit cost 26 bps well inside <45 bps guidance. Recovery & upgrade rate 92% of fresh slippage.
ROE guidance met on schedule: 13.61% this quarter vs. 13.5% FY27 target; 14.5% guided for FY28. Sequential metrics all hit (cost, GNPA, NNPA, ROE).
Revenue-to-asset growth disconnect: advances up 17%, deposits up 20%, but revenue only 9.4% year-on-year. A 55% lag between asset growth and top-line growth is not normal—it flags yield compression, mix deterioration, or quality shift.
Profit growth leans on cost compression, not operating leverage: deposit repricing benefit (14 bps Q4-to-Q1) is natural, not repeatable at the same magnitude. Repricing tail fading into Q2 per management. Fee spike (+31% YoY) softened by ₹85 Cr treasury loss and Q1 seasonality.
Core growth engines underperforming: mortgages 1% QoQ (flat) despite prior 'acceleration' language; MSME/SME disbursals in decline for multiple quarters with no near-term visible payoff.
Gold loan concentration rising rapidly: now 20–22% of portfolio (₹7–7.5k Cr), up 100% year-on-year. Bank caps LTV at 75% (vs. RBI's 85%), signaling competitive pressure. If competition forces higher LTV or if gold prices fall further, margin and credit risk both worsen.
Market verdict—the stock tells its own story
DCB announced results on Friday, 24 July 2026, to a pre-result close of ₹187.33. The day-1 pop was +1.56% on 41.7% delivery volume—modest enthusiasm. By day 3, the move had built to +2.79%. But by day 5, the pop had faded to −0.66%. The market's own verdict: interesting quarter, but not enough to hold conviction. That fade mirrors the fundamental read—a cost story that markets have already priced, without proof that revenue growth can re-accelerate.
₹186.09
−8.95% from ATH ₹204.39
₹127.41–₹204.39
+46% from low, −9% from high
₹184.28 / ₹179.13
trading above both; structural bid intact
41.8
neutral zone; room to move either way
Ownership flows tell a mixed story. FII added 71 basis points quarter-on-quarter (to 12.64% from 11.93%), and DII added 65 basis points (to 32.80% from 32.15%), but these are modest builds—not the aggressive accumulation you'd see if the street was convinced the growth story is back. Promoter holding flat at 16.43%. Volume trend is increasing, suggesting either risk-off positioning or gradual redistribution. The stock remains above its 50-day and 200-day moving averages, but the post-result fade and modest ownership growth suggest wait-and-see positioning into Q2.
Risks, ranked by how much they should concern a holder
Revenue-to-asset growth disconnect persists
HighAdvances 17%, deposits 20%, revenue 9.4%. If this gap remains through H2, it signals either (a) yield compression that erodes margin expansion, or (b) deteriorating earning-asset quality that will show up in credit costs later. Both are serious.
Deposit repricing benefit fading faster than expected
Medium14 bps reduction Q4-to-Q1 vs. 7–8% guided forward. Management didn't explain the cliff. If repricing is exhausted by Q2, NIM upside evaporates and cost discipline alone carries less of the profit growth story.
Mortgage growth doesn't materialize despite disbursal momentum
MediumDisbursals up 35% YoY but stock growth only 1% QoQ. If churn / premature closures / balance transfers continue to eat into growth, the bank's claimed 22–23% revenue growth path is a fantasy. This is the single biggest catalyst claim on the call.
Gold loan concentration and LTV pressure
Medium20–22% of portfolio, 100% YoY growth, LTV capped at 75%. If competitive pressure forces the bank to loosen LTV or cut rates, credit risk rises and yields compress simultaneously. Credit loss is low today (negligible NPA), but risk is embedded.
MSME/SME turnaround delayed or doesn't happen
MediumDisbursals down YoY for multiple quarters. Q2–Q3 inflection is a placeholder. If turnaround delays, the bank is left with declining SME/MSME book and no path to trade finance income uplift. Growth profile weakens further.
The honest debate
What to watch next
1 · Mortgage stock growth (the lead indicator test)
Q1 disbursals up 35% YoY but stock growth flat (1% QoQ). If Q2 stock growth (advances) accelerates to 5%+ QoQ or 18%+ YoY, disbursal momentum is flowing through and the 22–23% growth story is credible. If it stays <2% QoQ, churn is eating gains and management's timeline is optimistic.
2 · Revenue growth rate (the acid test)
Q1 revenue 9.4% YoY. Management targets 15–18% by year-end if mortgage and MSME inflect. Q2 revenue growth either re-accelerates toward 12%+ YoY or it stays in single digits. If single digits persist into Q2-Q3, the earned-asset quality or yield story is broken and the bank becomes a cost-efficiency play, not a growth play.
3 · NIM trajectory and deposit repricing residue
Q2 will show whether the repricing tail fades as quickly as management now guides (7–8% forward decline vs. 14 bps delivered). If NIM compresses faster than expected or deposit repricing reverses, cost-of-fund leverage evaporates and margin expansion story flattens. The ₹85 Cr treasury loss and fee spike sustainability also matter here.
The single number to track
Revenue growth rate. If it re-accelerates to 12%+ YoY in Q2 (vs. 9.4% Q1), the cost discipline is being deployed to fund top-line acceleration and the ROE roadmap is on track. If it stays <10% YoY, cost wins are being surrendered to fund weakness elsewhere, and the quarter-on-quarter profit growth story becomes a grind. At ₹186, the stock is fairly priced on the holding case—steady execution, not step-change. Revenue growth is the hinge that turns this from a hold into either a buy (if re-accelerating) or a sell (if re-decelerating further). Watch Q2 closely.
DCB Bank delivered on its FY27 quarterly targets—cost, credit, ROE all hit or beat guidance. That consistency is real and undervalued. But profit growth outpacing revenue growth, on the back of a shrinking deposit-repricing arbitrage, is a story that has legs only if the revenue engine restarts in the next two quarters. The post-result stock fade (pop +2.79% by day 3, back to −0.66% by day 5) and modest institutional buying (FII +71 bps, DII +65 bps) suggest the street is in wait-and-see mode. That's the right stance here. Hold the position on cost discipline and asset quality; take profits or add if revenue growth shows proof in Q2.
Strong PAT growth masks slowing revenue; cost discipline proven, growth mechanisms untested
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met FY27 quarterly targets (ROE 13.61% vs 13.5% guide, cost 2.42% vs 2.5%). Missed implied mortgage growth (10% vs ~18-20% suggested by prior guidance). MSME declining vs expectations.
Neutral
next 1–2 quarters
Optimistic
multi-year
Strong cost discipline and asset quality delivered (cost-to-AA 2.42%, credit cost 26 bps, GNPA down 55 bps to 2.43%), backing reaffirmed FY27 ROE guidance of 13.5%. However, revenue growth (9.4% YoY) lags sharply behind asset growth (17% advances, 20% deposits), and core growth engines underperform: mortgages at 1% QoQ despite prior guidance of acceleration, MSME in decline. Deposit repricing tailwind shortening. Valuation merits holding pending Q2 evidence of mortgage/MSME inflection.
₹1984.3 Cr
Revenue · +9.4% YoY₹213.2 Cr
Reported PAT · +35.6% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
Highest ever quarterly profit ₹213 Cr
METPAT ₹213.2 Cr delivered, 35.6% YoY growth
Asset growth 18-20%; mortgages accelerating
OVERSTATEDAdvances 17.06% YoY (met floor), mortgages 10% YoY, 1% QoQ (flat/disappointing)
NIM benefits from deposit repricing into Q2
MixedNIM 3.35% (+15 bps YoY), cost-of-deposit -14 bps QoQ; management now hedges expecting 7-8% future decline vs 14 bps achieved
Cost-to-average-assets maintained ~2.5%
MET2.42% delivered, beat guidance by 8 bps
Credit costs <45 bps
MET26 bps delivered
Revenue growth driven by deposit/advance growth momentum
MISSRevenue only 9.4% YoY, 4% QoQ despite 20% deposit, 17% advance growth (significant lag)
Earnings quality
What changed since the last call
Mortgage growth outlook dimmed
DowngradePrior call suggested acceleration; delivered 10% YoY, 1% QoQ. Management blamed strategic shift (stopped DA), expects 22-23% if disbursal trend (35% higher than prior year) persists—but validation pending.
NIM durability questions raised
DowngradeManagement walked back deposit repricing benefit expectations. From 14 bps reduction QoQ, now guides 7-8% decline forward. Repricing tail into Q2 but shortening faster than prior guidance suggested.
Capital raise deferred
WithdrawnPrior guidance: late Q2 or early Q3 FY27. Management now says no urgency; capital adequacy improved to 14.9% from 14.26%. Timing TBD, signaling lower capex ambitions or slower deployment.
Cost-to-AA overdelivered
UpgradeDelivered 2.42% vs 2.5% guidance. Management says headroom remains (target 2.45% full-year) but offset by staff hiring (11,500 → ~13,000 guided). Efficiency gains being reinvested in growth.
MSME acknowledged as drag
NewMSME disbursals down YoY. Management stopped TReDS (low-yielding), hiring specialists, targeting Q2-Q3 inflection. Positions as investment phase, not a structural weakness—credibility TBD.
The Q&A
Analysts pressed hard on mortgage underperformance (Akshat, M.B. Mahesh: only 10% YoY, 1% QoQ). Questioned NIM durability given rate stickiness (Krishnan ASV). Probed MSME drag (Parth Gutka, Punit Bahlani, Devam Modi). Challenged gold loan competitive/concentration risk (Param Subramanian). Management held firm on strategy (stopped DA, conservative LTV, organic-only mortgages) and cited disbursal momentum as lead indicator, but gave ground on timeline—expectations reset for Q2-Q3, not Q1. No serial misses, but guidance sequencing suggests near-term growth challenges acknowledged.
Margin & NIM trajectory — Akshat Agarwal, Nirmal Bang
AnsweredYield at 10.75% due to gold loan mix (lower yield, lower cost, minimal credit). Expect mortgage mix to improve Q2-Q4. Cost-of-deposit down 14 bps Q4-Q1; expect 7-8% decline forward if portfolio quality held.
CASA ratio strategy — Chetan Sharma, Systematix
PartialCost-of-deposit fell despite CASA decline (7.18% to 6.75%), showing cost-of-fund matters more than CASA ratio. CA growth only 5% YoY is area for improvement. Focused on cost-of-fund metric, not CASA mix.
Mortgage growth momentum — M.B. Mahesh, Kotak
AnsweredNo intentional slowdown. Stopped DA sourcing (better yield, quality, cross-sell from organic). Disbursals up 35% YoY (₹1,500 vs ₹1,100 Cr), real lead indicator. Expect growth to outpace bank if momentum maintained.
NIM guidance stable — M.B. Mahesh, Kotak
AnsweredExpect upward curve in yield, cost-of-deposit reduction of 7-8% (vs 14 bps Q4-Q1). If portfolio quality held, NIM will improve Q2 onwards.
Seasonality normalization — Jai Mundhra, ICICI Securities
AnsweredGuided with clear timelines on cost, NPA, ROE for FY27 (13.5%) and FY28 (14.5%). Executing efficiency improvements from past 12-18 months. Every quarter shows calibrated growth, not hockey stick.
Co-lending growth outlook — Jai Mundhra, ICICI Securities
AnsweredGuidance is co-lending ≤15% of advances. Currently 12.5%; room for 2.52% more. Prefer organic lending to grow, co-lending in 13-14% range. Will not rely on co-lending for growth.
Gold loan risk framework — Jai Mundhra, ICICI Securities
AnsweredRBI allows 85% LTV; we cap at 75% max at all branches. Growth achieved at 75% LTV proves 10% buffer is enough. Benefit of hindsight: gold was ₹17,000/gm mid-quarter, fell to ₹14,400; 85% LTV would have meant 100% LTV today and margin calls. Co-lending goes to 85%, organic stays at 75%.
Deposit repricing residue — Parth Gutka, 360 ONE
AnsweredQ2 also has repricing tail benefit from long-duration deposits. Guiding to stay below 2.5%, try to keep at 2.45% full-year. Denominator growing helps. Q1 has salary cost hit; future quarters should improve or maintain.
SME/MSME strategy — Punit Bahlani, Dolat Capital
AnsweredMSME is area we want to grow; stopped TReDS (low-yield). Focused on current account (5% YoY growth, opportunity), MSME OD, trade finance. Not seeing output yet, but Q3 should show benefit of investments in people, technology, new sectors.
Margin trajectory and SME uplift — Punit Bahlani, Dolat Capital
AnsweredDeposit repricing is natural, not automatic. Getting fresh deposits at lower rates now (was among highest payers earlier, that's changing). Sourcing mix change (mortgages higher yield than organic loans) will add to yield improvement. Strategy: reduce cost-of-deposit, maintain portfolio quality, change product mix. SME is ₹1,800 Cr book; ₹29,000 Cr mortgage book can alter destiny.
Cost-of-AA bottom — Param Subramanian, Investec
AnsweredExpect staff count to increase from 11,500 to ~13,000 (digital talk aside, still need feet on street for sales). Some efficiency will be consumed by incremental salary. Will try to keep below 2.5%, aim for 2.45% full-year.
Gold loan competitive pressure — Param Subramanian, Investec
DodgedWe don't give product-wise yields. Frontline always says there's pressure, but fact is we grow at 75% LTV vs 85% given by others. 10% LTV gap is material. Haven't seen pricing pressure in Q4-Q1 on organic book. If pressure comes, we'll revisit approach.
Branch expansion strategy — Vaibhav Mehta, Axis MF
AnsweredMaybe 20 branches this year, probably 500 by year-end. Not branch-focused for growth. Next 2-3 years, branch not central. Focus on second/third branches in existing cities (increased penetration). More people increase than branch increase, proportionally.
MD tenure and capital raise timing — Vaibhav Garg, VPPL
AnsweredToo early to discuss extension; board hasn't spoken. Personal choice: been in bank 19 years, could work another 19. On fundraising: Tier 1 capital up to 14.9% from 14.26%; CRAR up to 17.03% from 16.66%. Very weird because banking is capital-guzzling. In good space, controlling RWA. Want capital to expand, not conserve. AGM passed ₹2,000 Cr enabling (₹1,500 Cr Tier 1). No urgency, open to conversations. Timing, quantum, pricing TBD by board.
Fee income sustainability — Devam Modi, Ardeko
AnsweredCore fee is repeatable, recurring by definition. Driven by third-party distribution (Q1 usually sleepy; we changed that) and processing fees (rise with disbursals). Q1 asset disbursal usually lukewarm; expect Q2-Q3 improvement. Trade finance (tied to SME current account) is opportunity but not yet paying off. Effort is patient, 3-4 quarters before results.
Mortgage rundown and churn — Devam Modi, Ardeko
AnsweredTwo things: stopped DA in 2024 (contributed to NPAs, still does). Mortgage book now fully organic. Disbursal today leads to growth tomorrow. 35% increase in disbursal won't show 35% growth, but sustained 30-35% disbursal growth Q1-Q4 will lead to 22-23% growth vs 9% current. Premature closures/takeovers: Q4 was aggressive, Q1 better. AI-driven retention system in place. Confident on mortgage growth.
MSME resilience and inflation — Krishnan ASV, HDFC Securities
AnsweredMSMEs are service-focused, not manufacturing. Services not impacted by tariffs/inflation so far. Moved up ticket size (bad DA in 2024 taught us). Slightly more resilient customer base. Credit bureaus show no big problems in our segments. But petrol price up ₹15 in 2 months should ripple. Corner-cutting visible everywhere (cup height, diameter reducing).
NIM legroom despite rate stickiness — Krishnan ASV, HDFC Securities
AnsweredAnswer lies in inefficiency. We were giving higher rates than required for growth for a decade (putting more money on market than needed). Delta between our rate and others decreasing—that's improving cost-of-funds. 45 bps over what others give is still good, don't need 65-120 bps. Movement from 120 to 70 helping. Theme of last 3 years: efficiency in productivity, cost-of-funds, capital utilization, output per person. We were generous; now leaner, meaner, fitter.
Guidance
No formal FY27 revenue target stated
LowManagement focused on asset growth 18-20% (delivered 17% advances), not revenue. Implied ~15-18% revenue CAGR from prior years, but Q1 at 9.4% YoY suggests caution
NIM to improve Q2 onwards; cost-of-deposit decline 7-8% forward
MediumReduced from prior quarter's optimism (was 14 bps QoQ decline). Repricing tail into Q2 but shortening. Offset by rising fixed deposit rates (25-30 bps hike recent months)
20 branches addition this year; ~500 branches by year-end
HighBranch-light strategy; focus on second/third branch in existing cities. More people increase than branch increase
Risks the call surfaced
Revenue growth deceleration
HighRevenue 9.4% YoY vs advances 17% YoY reveals earning asset yield challenge. Asset base growing fast but translating to revenue at 55% the growth rate. Secured-heavy portfolio (gold 22%, mortgages 29k Cr) carries lower inherent yields.
Deposit repricing tail risk
MediumCost-of-deposit came down 14 bps Q4-Q1 due to repricing, driving much of NIM expansion. Management now guides 7-8% decline forward, implying repricing benefit substantially diminished by Q2. Fixed deposit rates raised 25-30 bps recent months; liquidity tightening could reverse cost momentum.
Gold loan concentration & LTV pressure
MediumGold loans grew 100% YoY, now 20-22% of portfolio (₹7-7.5k Cr). Management caps LTV at 75% vs RBI's 85%, defending against competitive pressure and price volatility. If LTV constraints loosen (competition) or gold prices fall further (collateral erosion), credit risk or margin pressure could follow.
MSME/SME turnaround uncertainty
MediumMSME disbursals down YoY for multiple quarters. Management stopped TReDS, invested in new sectors/staff. Benefits expected Q2-Q3 remain unproven. If turnaround delays, growth profile weakens further and trade finance (tied to SME current account) lags.
Mortgage growth not yet materializing
MediumMortgages at 10% YoY, 1% QoQ (flat/disappointing) despite prior guidance of acceleration. Disbursal momentum (₹1,500 Cr vs ₹1,100 Cr YoY, +35%) a leading indicator, but lag between disbursal and stock growth suggests retention/churn headwinds or timing mismatch.
Management
Score 7/10. Mostly transparent; direct on numbers and strategy. Deflected on product-wise yields (gold loan), avoiding competitive sensitivity. Candid on MSME drag, deposit repricing tail fading, and mortgage underperformance. Hedged on timeline for MSME/SME inflection and future NIM trajectory. Track record strong on Q1 targets (cost, GNPA, NNPA, ROE all met vs guidance). Missed implicit mortgage acceleration narrative. On multi-quarter basis (4 of last 4 quarters called 'highest ever'), showing consistency. Cost discipline proven (11.06 Cr business per employee, down 2-year headcount despite 18.5% growth).
1 · Q2 FY27
Mortgage disbursements continue 35% growth trajectory; if sustained, should lift growth rate materially (management targets 22-23% vs 9% current)
2 · Q2 FY27
MSME inflection: new hires and sector expansion begin to show in disbursements and current account growth (management expects visible Q2 benefit)
3 · Q2-Q3 FY27
Deposit repricing benefit continues (management confirms Q2 tail still present), though at lower magnitude (7-8% vs prior 14 bps)
Valuation merits holding pending Q2 evidence of mortgage/MSME inflection.